# Provasculon

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/provasculon

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Total disclosed funding: $6M
- Latest round: Series A (Mar 20, 2008)
- Investors on record: 2

## About

Founded in 2007 and based in Massachusetts, US, Provasculon, Inc. is a biotechnology company that develops novel forms of stromal cell-derived therapeutic proteins to treat patients with cardiovascular diseases and diabetic ulcers.

## Funding rounds

- Series A, Mar 20, 2008, $6M — Biogen Idec New Ventures, Mass General Brigham Ventures

## Investors

- Biogen Idec New Ventures (https://capitalatlas.ai/funds/biogen-idec-new-ventures) — Series A
- Mass General Brigham Ventures (https://capitalatlas.ai/funds/mass-general-brigham-ventures) — Series A